search
Back to results

Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise

Primary Purpose

Immune Markers, Complete Blood Count (CBC) With Platelet Differentials, Muscle Damage

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active Probiotic Culture
Inactive Probiotic Culture
Sponsored by
Lindenwood University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Immune Markers

Eligibility Criteria

18 Years - 55 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Male
  • Free from any disorders or diseases as stated on health history form
  • Between the ages of 18 - 55 years of age

Exclusion Criteria:

  • Currently being treated for or are diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, obesity (defined as body mass index > 30 kg/m2 and body fat greater than 30%), immune, autoimmune, hematological, neurological or endocrinological disorder or disease unless the scenario is viewed to not be a contraindication by the clinical coordinator of the study protocol. Individuals who are currently prescribed a hypertensive or cholesterol-lowering medication will be allowed entry into the study with clearance from clinical coordinator or their personal physician.
  • Female
  • An individual who is less than 18 and greater than 55 years of age will be excluded.
  • Participants younger than 18 are excluded due to necessity of parental consent.
  • Participants greater than 55 years old lie outside of the target demographic for the current study.
  • Considered to be sedentary, defined as getting less than 30 minutes of moderate intensity physical activity for most days of the week.
  • Currently not resistance training at least 2 days per week for the past 30 days
  • Currently smoking or have quit smoking within the past 6 months
  • Currently taking a probiotic. Individuals who currently report as taking a probiotic will be allowed entry into study protocol if a wash-out period of 30 days is observed.)
  • Currently consuming any form of dietary supplements that are viewed by study investigators to confound the outcomes of the study protocol (i.e., creatine, beta-alanine, essential amino acids, beta-hydroxy-beta-methylbutyrate (HMB), branched-chain amino acids, or any pre-workout that contain combinations of these ingredients). Individuals who currently report as taking any of these supplements will be allowed entry into study protocol if a wash-out period of 30 days is observed.

Sites / Locations

  • Lindenwood University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Active Probiotic Culture

Inactive Probiotic Culture

Arm Description

Active culture of Bacillus Coagulans Dose: 1 x 10^9 colony forming units (CFU)

Inactive culture of Bacillus Coagulans (GBI-30, 6086) - Marked as "StaImune" Dose: 1 x 10^9 colony forming units (CFU)

Outcomes

Primary Outcome Measures

Immune Markers
C-reactive protein [milligrams per liter (mg/L)]
Complete blood count
White blood cell and platelet count [Thousand per microliter (Thousand/uL)]
Markers of muscle damage
Creatine kinase [Units per liter (U/L)]
Force production assessment
Maximal voluntary isometric contraction (knee extension) [pounds (lb)]
Force production assessment
Isometric mid-thigh pull [pounds (lb)]
Countermovement Jump
peak force [Newtons (N)]
Countermovement Jump
eccentric force [Newtons (N)]
Countermovement Jump
eccentric rate of force development [Newtons (N)]
Countermovement Jump
reactive strength index
Dynamic muscular fatigue
Biodex 50-repetition test [Percent fatigue rate]
Perceived soreness
Soreness questionnaire (0 - 10) 0 is low, 10 is high
Perceived soreness
pain-pressure threshold via algometer [Newtons (N)]
Immune Marker
Interleukin-6, Tumor necrosis factor-alpha, Monocyte chemoattractant protein 1 [picograms per milliliter (pg/mL)]
Markers of muscle damage
Myoglobin [nanogram per milliliter (ng/mL)].
Complete blood count (CBC)
Red blood cell count [Millions per microliter (million/uL)]
Complete blood count (CBC)
Hemoglobin and Mean corpuscular hemoglobin concentration (MCHC) [grams per deciliter (g/dL)]
Complete blood count (CBC)
Hematocrit, neutrophils, lymphocytes, monocytes, eosinophils, basophils,Red cell distribution width (RDW) [Percentage (%)]
Complete blood count (CBC)
Mean corpuscular volume (MCV) and Mean platelet volume (MPV) [Femtoliters (fL)]
Complete blood count (CBC)
Mean corpuscular hemoglobin (MCH) [Picograms (pg)]
Complete blood count (CBC)
Absolute neutrophils, absolute lymphocytes, absolute monocytes, absolute eosinophils, absolute basophils [cells per microliter (cells/uL)]

Secondary Outcome Measures

Full Information

First Posted
June 12, 2020
Last Updated
April 4, 2022
Sponsor
Lindenwood University
search

1. Study Identification

Unique Protocol Identification Number
NCT04441840
Brief Title
Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise
Official Title
Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
April 16, 2019 (Actual)
Primary Completion Date
August 1, 2021 (Actual)
Study Completion Date
August 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lindenwood University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study proposal seeks to examine the efficacy of probiotic supplementation at mitigating changes in immune function and recovery after completion of intense, stressful exercise while also allowing for a better understanding of its ability to promote recovery and maintenance of physical performance.
Detailed Description
Study Visit 1 - Familiarization: During the familiarization visit, participants will first read and sign an IRB-approved informed consent document and complete a short form of the International Physical Activity Questionnaire (IPAQ). Participants will then have their height, weight, and body composition determined using Dual-Energy X-ray Absorptiometry (DEXA) (Hologic Discovery A). To standardize body composition assessment, participants will be required to observe an 8-hour fast and maintain a well-hydrated state. Each participant will provide a urine sample to confirm a hydrated stated through determination of a urine specific gravity values greater 1.020. Participants will then complete a peak oxygen consumption test (VO2Peak) using indirect calorimetry on a ParvoMedics TrueOne (Sandy, UT) metabolic cart interfaced to a motorized cycle ergometer (Lode Corival). The peak oxygen consumption test protocol will require each study participants to start at 100 watts before progressively increasing by 1 watt every two seconds. To determine whether maximal effort occurred a respiratory exchange ratio of >1.00 must be achieved. Following the peak oxygen consumption assessment, participants will perform practice repetitions of all performance tests (force plate vertical jumps, isometric mid-thigh pulls, Biodex isometric and isokinetic knee extensor testing) as well as the exercises that will be performed during Visit 3 (leg press, hex bar deadlift, and drop jump). Study Visit 2 - Pre-Supplementation Baseline Testing: Study participants will be asked to complete a 24-hour food recall between each testing condition and will be asked to replicate their diet prior to this visit for all subsequent visits. Upon arrival, participants will first have their blood drawn from a forearm vein before completing a perceived soreness, pressure-pain threshold, and recovery assessment. Prior to testing, participants will complete the same standardized warm-up consisting of 5 minutes of light cycling, 10 body weight squats, 10 body weight walking lunges, 10 dynamic walking hamstring stretches (straight-leg march), and 10 dynamic walking quadriceps stretches. After the warm-up, participants will complete five countermovement jump squats on top of bilateral triaxial force plates (Hawkins Dynamics) interfaced to a personal computer to derive relevant force-time variables. Next, participants will complete two assessments of peak isometric force production. Using an electronic load cell with a 5,000-N capacity (Load Star load cells) connected to a computer, three 5-second maximal isometric mid-thigh pulls will be completed. Participants will then be outfitted on a Biodex isokinetic dynamometer where they will complete three maximal isometric knee extensions. Following the isometric knee extensor testing, participants will complete a 50-repetition test of concentric-only repetitions to assess changes in force production, torque, and rates of fatigue development. After the baseline performance testing, participants will have their leg press and hex bar deadlift one-repetition maximum (1RM) determined. *Supplementation (14 days, described below) followed by exercise trial.* Study Visit 3 (Post-Supplementation Testing, Exercise Trial): Upon arrival, study participants will be asked to complete a 24-hour food recall and between each testing condition, study participants will be asked to replicate their diet. Upon arrival, participants will first have their blood drawn from a forearm vein before completing perceived soreness, pressure-pain threshold, and recovery assessments. Prior to testing, participants will complete the same standardized warm-up consisting of 5 minutes of light cycling, 10 body weight squats, 10 body weight walking lunges, 10 dynamic walking hamstring stretches (straight-leg march), and 10 dynamic walking quadriceps stretches. After the warm-up, participants will complete five countermovement jump squats on top of bilateral triaxial force plates (Hawkins Dynamics) interfaced to a personal computer to derive relevant force-time variables. Using an electronic load cell with a 5,000-N capacity (Load Star load cells) connected to a computer, three 5-second maximal isometric mid-thigh pulls will be completed. Participants will then be positioned on a Biodex isokinetic dynamometer where they will complete three maximal isometric knee extensions. Lastly, participants will complete a 50-repetition test of concentric-only repetitions to assess changes in force production, torque, and rates of fatigue development. Following the completion of these tests, participants will perform an exercise trial according to the methods described below. Following completion of the exercise trial, participants will undergo the previous testing battery (blood sample, perceived soreness, pressure-pain threshold assessment, recovery assessment, countermovement vertical jumps, isometric mid-thigh pulls, Biodex isometric and isokinetic testing) at five time points: immediately after exercise, 30 minutes post-exercise, 1 hour, 2 hours, and 5 hours post-exercise. Study Visits 4 - 6: Post-Exercise Performance In an identical fashion, with the exception of 1RM assessment, study visits 4, 5, and 6 will be completed 24, 48, and 72 hours, respectively, after completion of the exercise bout. Briefly, study participants will return to the laboratory after an overnight fast (10 hours). Participants will bring in the completed 24-hour dietary recall, donate venous blood samples, assess their soreness, pressure-pain threshold, and recovery, complete the warm-up, perform five countermovement jumps, assess peak isometric force production, and complete a 50-repetition muscle fatigue test during each visit.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Immune Markers, Complete Blood Count (CBC) With Platelet Differentials, Muscle Damage, Muscular Force Production, Countermovement Jump, Muscular Fatigue, Muscular Soreness

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Masking Description
The supplements were delivered in identical containers, each marked with a separate code marked on the outside of the supplement container. Once data collection, data entry, and statistical analysis was completely finished, the study code was broken.
Allocation
Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active Probiotic Culture
Arm Type
Active Comparator
Arm Description
Active culture of Bacillus Coagulans Dose: 1 x 10^9 colony forming units (CFU)
Arm Title
Inactive Probiotic Culture
Arm Type
Active Comparator
Arm Description
Inactive culture of Bacillus Coagulans (GBI-30, 6086) - Marked as "StaImune" Dose: 1 x 10^9 colony forming units (CFU)
Intervention Type
Dietary Supplement
Intervention Name(s)
Active Probiotic Culture
Intervention Description
Both conditions matched in appearance and serving size
Intervention Type
Dietary Supplement
Intervention Name(s)
Inactive Probiotic Culture
Other Intervention Name(s)
StaImune
Intervention Description
Both conditions matched in appearance and serving size
Primary Outcome Measure Information:
Title
Immune Markers
Description
C-reactive protein [milligrams per liter (mg/L)]
Time Frame
Three weeks
Title
Complete blood count
Description
White blood cell and platelet count [Thousand per microliter (Thousand/uL)]
Time Frame
Three weeks
Title
Markers of muscle damage
Description
Creatine kinase [Units per liter (U/L)]
Time Frame
Three weeks
Title
Force production assessment
Description
Maximal voluntary isometric contraction (knee extension) [pounds (lb)]
Time Frame
Three weeks
Title
Force production assessment
Description
Isometric mid-thigh pull [pounds (lb)]
Time Frame
Three weeks
Title
Countermovement Jump
Description
peak force [Newtons (N)]
Time Frame
Three weeks
Title
Countermovement Jump
Description
eccentric force [Newtons (N)]
Time Frame
Three weeks
Title
Countermovement Jump
Description
eccentric rate of force development [Newtons (N)]
Time Frame
Three weeks
Title
Countermovement Jump
Description
reactive strength index
Time Frame
Three weeks
Title
Dynamic muscular fatigue
Description
Biodex 50-repetition test [Percent fatigue rate]
Time Frame
Three weeks
Title
Perceived soreness
Description
Soreness questionnaire (0 - 10) 0 is low, 10 is high
Time Frame
Three weeks
Title
Perceived soreness
Description
pain-pressure threshold via algometer [Newtons (N)]
Time Frame
Three weeks
Title
Immune Marker
Description
Interleukin-6, Tumor necrosis factor-alpha, Monocyte chemoattractant protein 1 [picograms per milliliter (pg/mL)]
Time Frame
Three weeks
Title
Markers of muscle damage
Description
Myoglobin [nanogram per milliliter (ng/mL)].
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Red blood cell count [Millions per microliter (million/uL)]
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Hemoglobin and Mean corpuscular hemoglobin concentration (MCHC) [grams per deciliter (g/dL)]
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Hematocrit, neutrophils, lymphocytes, monocytes, eosinophils, basophils,Red cell distribution width (RDW) [Percentage (%)]
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Mean corpuscular volume (MCV) and Mean platelet volume (MPV) [Femtoliters (fL)]
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Mean corpuscular hemoglobin (MCH) [Picograms (pg)]
Time Frame
Three weeks
Title
Complete blood count (CBC)
Description
Absolute neutrophils, absolute lymphocytes, absolute monocytes, absolute eosinophils, absolute basophils [cells per microliter (cells/uL)]
Time Frame
Three weeks

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male Free from any disorders or diseases as stated on health history form Between the ages of 18 - 55 years of age Exclusion Criteria: Currently being treated for or are diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, obesity (defined as body mass index > 30 kg/m2 and body fat greater than 30%), immune, autoimmune, hematological, neurological or endocrinological disorder or disease unless the scenario is viewed to not be a contraindication by the clinical coordinator of the study protocol. Individuals who are currently prescribed a hypertensive or cholesterol-lowering medication will be allowed entry into the study with clearance from clinical coordinator or their personal physician. Female An individual who is less than 18 and greater than 55 years of age will be excluded. Participants younger than 18 are excluded due to necessity of parental consent. Participants greater than 55 years old lie outside of the target demographic for the current study. Considered to be sedentary, defined as getting less than 30 minutes of moderate intensity physical activity for most days of the week. Currently not resistance training at least 2 days per week for the past 30 days Currently smoking or have quit smoking within the past 6 months Currently taking a probiotic. Individuals who currently report as taking a probiotic will be allowed entry into study protocol if a wash-out period of 30 days is observed.) Currently consuming any form of dietary supplements that are viewed by study investigators to confound the outcomes of the study protocol (i.e., creatine, beta-alanine, essential amino acids, beta-hydroxy-beta-methylbutyrate (HMB), branched-chain amino acids, or any pre-workout that contain combinations of these ingredients). Individuals who currently report as taking any of these supplements will be allowed entry into study protocol if a wash-out period of 30 days is observed.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chad Kerksick, PhD
Organizational Affiliation
Laboratory Director
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lindenwood University
City
Saint Charles
State/Province
Missouri
ZIP/Postal Code
63301
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
All approved unidentified study data inside the laboratory will be saved within a research repository bank for future research questions. Otherwise, participant data will be destroyed after three years of study completion to maintain Institutional Review Board (IRB) compliance

Learn more about this trial

Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise

We'll reach out to this number within 24 hrs